相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
Susanne H. Hodgson et al.
LANCET INFECTIOUS DISEASES (2021)
Dengue vaccine development: status and future
Annelies Wilder-Smith
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2020)
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Noah C. Peeri et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)
Is COVID-19 receiving ADE from other coronaviruses?
Jason A. Tetro
MICROBES AND INFECTION (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Profile of specific antibodies to SARS-CoV-2: The first report
Ai Tang Xiao et al.
JOURNAL OF INFECTION (2020)
Detection of antibodies against SARS-CoV-2 in patients with COVID-19
Zhe Du et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani et al.
MOLECULAR PHARMACOLOGY (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment
Takahiko Koyama et al.
PATHOGENS (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Genetic diversity and evolution of SARS-CoV-2
Tung Phan
INFECTION GENETICS AND EVOLUTION (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
COVID-19 vaccine development pipeline gears up
Asher Mullard
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
The immune system and COVID-19: Friend or foe?
Fereshteh Yazdanpanah et al.
LIFE SCIENCES (2020)
All eyes on the hurdle race for a SARS-CoV-2 vaccine
Christian Gaebler et al.
NATURE (2020)
Evolution of the COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse et al.
FRONTIERS IN IMMUNOLOGY (2020)
Genomic characterization of a novel SARS-CoV-2
Rozhgar A. Khailany et al.
GENE REPORTS (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
Arash Keshavarzi Arshadi et al.
FRONTIERS IN ARTIFICIAL INTELLIGENCE (2020)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Angiotensin-converting enzyme in innate and adaptive immunity
Kenneth E. Bernstein et al.
NATURE REVIEWS NEPHROLOGY (2018)
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Katie Ewer et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
Katherine V. Houser et al.
PLOS PATHOGENS (2017)
Simian adenoviruses as vaccine vectors
Susan J. Morris et al.
FUTURE VIROLOGY (2016)
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination
Dominique Le Houezec
IMMUNOLOGIC RESEARCH (2014)
Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States
Jonathan Duffy et al.
NEUROLOGY (2014)
Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
Markku Partinen et al.
PLOS ONE (2012)
Fundamentals of Vaccine Immunology
Angela S. Clem
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2011)
Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells
Cheng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
Robson A. S. Santos et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hepatitis B vaccination and the risk of multiple sclerosis
A Ascherio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
